Table 2.
In vitro and in vivo gene expression of luciferase enzyme from PLG-CTAB-luciferase DNA formulations
| Formulation | DNA dose | In vitro luciferase expression in HeLa cells, pg | In vivo luciferase expression in muscle (pg) day 1 | In vivo luciferase expression in muscle (pg) day 14 |
|---|---|---|---|---|
| PLG/CTAB-Luc DNA | 5 μg | 1,248 ± 122 | — | — |
| Luc DNA alone | 5 μg | 2,250 ± 240 | — | — |
| PLG/CTAB-Luc DNA | 50 μg | — | 9.51 | 44.95 |
| Luc DNA alone | 50 μg | — | 6.78 | 9.29 |
In vitro gene expression was carried out in HeLa cells with pLuc DNA released from PLG/CTAB formulation and unformulated DNA at day 1. The luciferase values have been normalized to total protein content. Mean ± SE of triplicate readings are represented. In vivo gene expression of luciferase enzyme was performed at days 1 and 14 with either the PLG/CTAB formulation or unformulated pLuc DNA.